On 30th December 2015, Resolution № 1163 "On Amendments to Some Resolutions of the Cabinet of Ministers of Ukraine” (hereinafter - Regulation), was adopted by the Cabinet of Ministers with which medical products procured through international organizations have easier access to Ukraine’smarket.
Therefore, the Regulation provides amendments to the technical regulations № 753, 754, 755 on medical products which were approved by the CMU from 02.10.2013., particularly for in vitro diagnostics and active medical implant devices.
Pursuant to the amendments, it will be permitted to enter the above mentioned medical products that are not bearing the national mark of conformity into circulation , subject to recognition of conformity from the designated conformity assessment body carried out by foreign accredited conformity assessment bodies , in accordance with the requirements of part three of Article 45 of the Law of Ukraine "On the Technical Regulations and Conformity Assessment", which in turn will take effect from 02.10.2016 year.
In particular, the above Article provides that national accreditation bodies are entitled to recognize the results of conformity assessment carried out by foreign authorities based on agreements with them , provided that :
This Regulation shall enter into force six months after the date of publication and will be valid until 31st March 2019.
It is to be noted that these legislative changes are due to the implementation of public procurement procedures of medical devices involving specialized international organizations that provide states and other entities with related services.
The event focused on the transformation of Ukraine's intellectual property sector on its path toward European integration.
Improving access to safe and affordable medicines for the Ukrainian population is one of the Government of Ukraine's top priorities. SAFEMed Activity (2017-2025) has supported this effort by appIying health system strengthening best practices.
The Ministry of Health website has posted a notice about the release of a revised draft order of the Ministry of Health ‘On Approval of Amendments to Certain Re
On 25 September, a webinar was held on the topic: ‘180 days of new drug price regulation. Results, prospects and practical advice.’ The event was organized by LA Law Firm in partnership with Proxima Research International.